GreyBrook logotype
Contact Us Contact Us

Changing the Lives of More than 20,000 Patients, 2021 Was A Year of Continued Growth for Greenbrook TMS

Date:
December 31, 2021
Share:

Greenbrook TMS (NASDAQ: GBNH, TSX: GTMS) is a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders founded by Greybrook and firm’s CEO, Bill Leonard, with 149 centres across the U.S. The company has provided nearly 1,000,000 treatments changing the lives of more than 20,000 patients and has achieved phenomenal growth over the past year through clinic acquisitions, and expansions into new therapies and treatment methods.

Greenbrook TMS was founded with the belief that mental health care as it then existed was failing too many people. Only 49% of patients respond to their first-round antidepressant medication. The other 51% endured lengthy cycles of medication trial-and-error with little improvement, often experiencing side effects like weight gain and sexual dysfunction which worsened their depression symptoms. We knew there had to be a better way.

In 2011, Greenbrook TMS opened its first location in Tysons Corner, Virginia, with a vision to bring together the best care teams and technology into a more personalized, more accessible, and most importantly more effective treatment experience.

Today, more than 10 years after launching that first centre, Greenbrook has provided nearly 1,000,000 treatments and changed the lives of more than 20,000 patients. “We have the largest clinical data set in the U.S., and our TMS patients experience a 62% response rate which is well above the current antidepressant medication therapy rates and that is for patients who have already failed other treatments”, explained Bill Leonard, CEO Greenbrook TMS. “Many of our patients achieve full remission from their depression symptoms—all with little to no side effects”.  With more than 40% growth since 2015, Greenbrook’s 149 centers span 17 states; each location offers state-of-the-art treatment technology in a soothing, spa-like environment, bringing the Greenbrook care experience to more communities. In early 2021, to complement Greenbrook’s deep expertise in depression treatment, the company piloted offering Spravato, a nasal esketamine spray that is FDA-approved for treatment resistant major depressive disorder.

“Our passion has always been fueled by the goal of changing patient’s lives for the better. Looking ahead, as the pandemic continues to disrupt all aspects of daily life, rates of depression continue to soar and the importance of and need for our work is greater than ever. To help meet treatment needs in the community, and building on our successes in 2021, we will expand our Spravato offering to 23 locations by the end of Q1 2022”.

“We are very proud of what the Greenbrook team has accomplished and their commitment to helping so many people. As we expand Greenbrook’s clinical footprint, we are excited to see the impact that TMS and other innovative therapies can have on the lives of patients struggling with mental health”, Elias Vamvakas, Chairman Greenbrook TMS and Chairman Greybrook Capital.

To learn more about Greenbrook TMS, visit www.greenbrooktms.com

 

Latest Insights

Archetto Woodbridge Towns Officially Sold Out

Portfolio Updates
January 10, 2022

After launching the sales and marketing phase in February 2021, our Woodbidge project with developer partner, Marlin Spring has successfully sold out. Located at Pine Valley and Major Mackenzie in Woodbridge, Ontario, this master-planned community will include a collection of…

Delos Canada Celebrates Their First Anniversary Since Toronto Office was Established in January 2021

Company News
January 3, 2022

Delos Canada was established to accelerate health and well-being in Canada’s indoor environments. For nearly a decade, Delos has been elevating health and well-being as central values in the spaces where we live, work, sleep and play. Recognizing a profound…

Changing the Lives of More than 20,000 Patients, 2021 Was A Year of Continued Growth for Greenbrook TMS

Company News
December 31, 2021

Greenbrook TMS (NASDAQ: GBNH, TSX: GTMS) is a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders founded by Greybrook and firm’s CEO, Bill Leonard, with 149 centres…

Over 95% Sold Out, Emerald Crossing in Shelburne Experiences Great Success

Portfolio Updates
December 15, 2021

Our Emerald Crossing project with Fieldgate Homes has continued to be well received by the market selling over 95% of the development and the limited remaining inventory will be gradually released to the market. With all necessary engineering approvals achieved,…

Phase 1 Homes Built and Occupied at Storybrook in Fergus

Portfolio Updates
December 13, 2021

Since our last update, we are pleased to report that over 95% of the homes that comprise Phase 1 and 2 have been sold, driving the decision to launch Phase 3 sales in November 2021, adding an additional 104 units…

Speedy Construction at Evoke Towns

Portfolio Updates
December 9, 2021

Since our last update, we are pleased to report that vertical construction has progressed expediently with foundations having been poured for 18 out of 20 blocks and framing started on 8 of the 20 blocks. We continue to project that…

Pre-Leasing Begins for Society Biscayne in Downtown Miami

Portfolio Updates
December 9, 2021

“Pre-leasing is always an exciting milestone to reach because it signifies that opening is right around the corner. We are pleased to begin planning for welcoming residents to Society Biscayne and look forward to seeing this new social community flourish…

Interior Work Progresses as Exterior Cladding Complete at Avenue & Park

Portfolio Updates
December 1, 2021

Greybrook and Stafford Homes’ elegant Avenue & Park mixed-use condominium development project is pleased to report exterior cladding has been completed and window installations are coming to an end. The finalization of the exterior cladding process has allowed for interior…

Delos’ School Air-Quality Study Sheds Light on How to Protect Other Industries

Company News
November 30, 2021

The Well Living Lab, in collaboration with the Mayo Clinic and the University of Minnesota, performed a study to find out if adding portable air purification units would help to keep the air clean from viruses and other harmful airborne…

Greybrook Team Takes Part in Movember

Multi-media
November 29, 2021

Since inception, Movember has proudly welcomed more than five million supporters and has funded more than 1,250 innovative men’s health projects across 20 countries, raising awareness and donations for testicular cancer, prostate cancer, mental health and suicide prevention. With the…

[geot_filter exclude_country="cn"]All Publications[/geot_filter][geot_filter country="cn"]所有出版物[/geot_filter]

Join our newsletter and keep up to date with our news & insights

Contact us